LIXTE BIOTECHNOLOGY HOLDINGS (LIXT) Stock Balance Sheet
NASDAQ:LIXT • US5393193017
Current stock price
3.71 USD
-0.27 (-6.78%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | 1.04M | 4.20M | 5.35M | 4.82M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 71.50K | 106.60K | 105.10K | 210.00K | 270.00K | |||
| Total Current Assets | 5.18M | 1.15M | 4.31M | 5.56M | 5.09M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.56M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 7.56M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL ASSETS | 12.73M | 1.15M | 4.31M | 5.56M | 5.09M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 595.40K | N/A | N/A | N/A | 0.00 | |||
| Accounts Payable | 436.50K | 83.20K | 156.80K | 230.00K | 230.00K | |||
| Other Current Liabilities | 301.20K | 235.10K | 157.10K | 170.00K | 80.00K | |||
| Total Current Liabilities | 1.33M | 318.30K | 313.90K | 390.00K | 300.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 439.00K | N/A | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 1.74M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 3.07M | 318.30K | 313.90K | 390.00K | 300.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -58.08M | -52.07M | -48.48M | -43.39M | -37.08M | |||
| Additional Paid In Capital | 66.01M | 49.39M | 48.98M | 45.06M | 38.37M | |||
| Minority Interest | 1.30M | N/A | N/A | N/A | N/A | |||
| Common Shares | 1.73M | 3.50M | 3.50M | 3.50M | 3.50M | |||
| Shares Outstanding | 8.79M | 2.25M | 2.25M | 1.66M | 1.37M | |||
| Tangible Book Value per Share | 0.90 | -1.19 | 0.22 | 1.01 | 0.94 | |||
| Total Shareholders' Equity | 9.66M | 827.20K | 3.99M | 5.17M | 4.79M | |||
| TOTAL LIABILITIES AND EQUITY | 12.73M | 1.15M | 4.31M | 5.56M | 5.09M | |||
| Statistics | ||||||||
| Current Ratio | 3.88 | 3.60 | 13.73 | 14.26 | 16.97 | |||
| Return On Assets (ROA) | -47.74% | -313.05% | -118.07% | -113.49% | -132.22% | |||
| Return On Equity (ROE) | -62.90% | -433.51% | -127.34% | -122.05% | -140.50% | |||
All data in USD , ROIC based on taxRate of 0.21